Targeting estrogen receptor improves progression-free survival in advanced breast cancer
Fulvestrant significantly increases progression-free survival in women with hormone-receptor-positive advanced breast cancer, particularly those with less aggressive lower-volume disease, researchers reported at the ESMO ...
Oct 8, 2016
0
1